Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Summit Therapeutics

Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure

Summit Therapeutics stock plunged Friday after its highly watched cancer drug failed to significantly improve overall survival.

Investors Business Daily

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

Investors Business Daily

Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics

Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery

BioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.

Investors Business Daily

Up 1,123% YTD, Is It Too Late to Buy This Breakout Biotech Stock?

Summit Therapeutics is a clinical-stage biotech company that has returned over 1,100% in 2024. Is the stock still a good buy right now?

Summit Therapeutics, With 85% Gain This Week, Rockets Again On $235 Million Sale

Summit Therapeutics stock rocketed again Thursday — adding onto an 85% gain this week — after raising $235 million in a private placement.

Investors Business Daily

Stocks Finish Higher on Support From Chip Stock Rebound

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.30%. Stocks on Monday posted moderate gains on some dip buying following last Friday’s sharp...

inkl

Read news from The Economist, FT, and more,
with one subscription

Stocks Climb on Strength in Chip Stocks

Stocks Climb on Strength in Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off on some...

5 Top-Rated Russell 2000 Stocks Crushing the Market in 2024

5 Top-Rated Russell 2000 Stocks Crushing the Market in 2024

With the Russell 2000 index taking a dip in 2024, these five top-rated RUT stocks are outshining their parent index and the broader market.

Chart of the Day: Summit Therapeutics Begins to Soar

Chart of the Day: Summit Therapeutics Begins to Soar

Caution: This company has had legal issues in the past. It is highly speculative. The Chart of the Day belongs to the oncology company Summit Therapeutics (SMMT) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha,...

People

Daina Graybosch

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Palantir Technologies

Dell Technologies

Leerink Partners

Summit Therapeutics

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

288,240 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play